Shaolin Capital Management’s Zura Bio ZURA Stock Holding History

Shaolin Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-450,000	Closed	-$4.59M	–	708
2022 Q4	$4.59M	Hold	450,000	–	–	0.14%	205
2022 Q3	$4.52M	Buy	450,000 +100,000	+29%	+$1M	0.12%	238
2022 Q2	$3.48M	Sell	350,000 -99,502	-22%	-$988K	0.08%	299
2022 Q1	$4.46M	Buy	+449,502	New	+$4.43M	0.11%	252

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Shaolin Capital Management's ZURA Position: Q1 2023 in Review

Shaolin Capital Management sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 450,000 shares — an estimated $4.59M sold.

Shaolin Capital Management first reported a position in ZURA in Q1 2022 and held it in 4 quarters. The position peaked at $4.59M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Shaolin Capital Management reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Shaolin Capital Management sold 450,000 Zura Bio shares in Q1 2023, an estimated $4.59M.
Shaolin Capital Management first reported a position in Zura Bio in Q1 2022 and held it in 4 quarters.
Shaolin Capital Management's Zura Bio position peaked at $4.59M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Shaolin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.